However, many of these studies have either not deeply compared MSI to MSS CD8+ T cell profiles or have only revealed subtle differences in CD8+ T cell features that do not properly align with vast clinical and immunotherapeutic differences between MSI and MSS CRC. The gene discussed is CD8A; the disease is colorectal carcinoma.